A new publication from The National Comprehensive Cancer Network® (NCCN) is now available. The guidance outlined is there to take some of the uncertainty out of the prostate cancer screening process. As Thomas A. Farrington, President and Founder, Prostate Health Education Network (PHEN) explains, “The NCCN Guidelines for Patients: Prostate Cancer Screening are divided into three segments by age, beginning at 40 for those traditionally considered at high risk, 45 to 75 for all others, and a category for individuals older than 75.” For patients, these guidelines mean less guessing and more clarity about when to get screened. Thomas serves as a patient advocate on the NCCN Guidelines Panel for Prostate Cancer Early Detection, and he added, “The clear guidance for people falling into each of these segments makes this a very easy-to-understand guideline for all and distinguishes it from other early detection guidelines and recommendations.” Screening guidelines come from years of research, evidence, and expert recommendations. It’s time to remove fear from the equation.
The Benefits of Prostate Cancer Screening Outweigh the Harms, According to New Patient Guidelines From NCCN
Free, comprehensive guidebook shows how prostate cancer screening has largely de-emphasized invasive testing in order to avoid unnecessary procedures and treatment while at the same time saving lives.
The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—has published a new book explaining the latest evidence and expert recommendations around prostate cancer screening. The new NCCN Guidelines for Patients®: Prostate Cancer Screening address the myths, taboos, and outdated information that cause too many people to avoid this basic, life-saving care. They are based on the trusted recommendations that providers rely on worldwide, put into simple, understandable language for everyone.